Home › Funds › ESSEX INVESTMENT MANAGEMENT CO LLC › NUVB
ESSEX INVESTMENT MANAGEMENT CO LLC position in NUVB
NUVATION BIO INC · Health Care
ESSEX INVESTMENT MANAGEMENT CO LLC reported holding 1,344,871 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 1.12% of its reported portfolio and ranking #16 among its reported holdings. ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How ESSEX INVESTMENT MANAGEMENT CO LLC's NUVB position evolved
ESSEX INVESTMENT MANAGEMENT CO LLC first disclosed a stake in NUVB in Q2 2026 at 671,041 shares (US$3.8M). The position peaked in Q3 2026 at 1,344,871 shares, worth US$7.5M. Across 2 filings, ESSEX INVESTMENT MANAGEMENT CO LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,344,871 shares valued at US$7.5M — an increase of 673,830 shares quarter over quarter.. Notable position changes include a 100% increase in Q3 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 671.04K | $3.81M | New |
| Q3 2026 | 1.34M | $7.53M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 53 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.82M sh · $44.42M · Q2 2026
- Context Capital Management, LLC 30.00M sh · $31.29M · Q2 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
- TANAKA CAPITAL MANAGEMENT INC 901.83K sh · $3.87M · Q1 2026
More on ESSEX INVESTMENT MANAGEMENT CO LLC
FAQ
How long has ESSEX INVESTMENT MANAGEMENT CO LLC held NUVB?
ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in NUVB?
As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 1.34M shares of NUVB (NUVATION BIO INC), valued at $7.53M, representing 1.12% of its reported portfolio and ranking #16.
Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling NUVB?
In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC increased its position in NUVB. The position peaked in Q3 2026 at 1.34M shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.